AWMF online

 

Arbeitsgemeinschaft der
Wissenschaftlichen
Medizinischen
Fachgesellschaften

Leitlinien der Dt. Ges. f. Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie


 AWMF-Leitlinien-Register  Nr. 017/010  Entwicklungsstufe:  2   nicht aktualisiert 

Hörsturz

Vorbemerkung

Definition

Notfall / Eilfall

Epidemiologie

Pathogenese / Ätiologie

Klassifikation

Differenzialdiagnostik

Klinik

Diagnostik

Therapie

Ambulant / Stationär

Prognose


Literatur

  1. AWMF online: Wissensbasierte Leitlinien für Diagnostik und Therapie - http://leitlinien.net -
  2. Alexiou C, Arnold W, Fauser C, Schratzenstaller B, Gloddeck B, Fuhrmann S, Lamm K (2001) Sudden sensorineural hearing loss: Does application of glucocorticoids make sense? Arch Otolaryngol Head Neck Surg 127:253-258
  3. Annesley-Williams DJ, Laitt, RD, Jenkins JP, Ramsden, RT, Gillespie JE (2001) Magnetic resonance imaging in the investigation of sensorineural hearing loss: is contrast enhancement still necessary? J Laryngol Otol 115:14-21
  4. Arzneimittelkommission der deutschen Ärzteschaft (2000) "UAW-News" - International: Hydroxyethylstärke (HES) - Juckreiz. Deutsches Ärzteblatt 97:B 2447
  5. Aslan I, Oysu C, Veyseller B, Baserer N (2002) Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness? Otolaryngol Head Neck Surg 126:121-126.
  6. Baujat B, De Minteguiaga C, Lecanu JB, Herman P, Tran Ba Huy P (2002) Les surdites brusques sont-elles une urgence therapeutique? Ann Otolaryngol Chir Cervicofac 119:3-11
  7. Beutter P, Guinard F, Jalbert D, Marsac A, Morin R, Sauvage JP, Soudant J (1990) Etude de l'interet de l'administration de la trimetazidine dans le traitement des surdites brusques, en association a l'hemodilution. A propos d'une etude multicentrique. Ann Otolaryngol Chir Cervicofac 107:345-350.
  8. Brookes GB, Booth JB (1984) Oral acetazolamide in Meniere's disease. J Laryngol Otol 98:1087-1095
  9. Burschka MA, Hassan HA, Reineke T, van Bebber L, Caird DM, Mosges R (2001) Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 out-patients. Eur Arch Otorhinolaryngol 258:213-219
  10. Byl FM (1977) Seventy-six cases of presumed sudden hearing loss occuring in 1973; prognosis and incidence. Laryngoscope 87:817-820
  11. Byl FM Jr.(1984) Sudden hearing loss: eight years' experience and suggested prognos-tic table.Laryngoscope 94:647-661
  12. Chen CY, Halpin C, Rauch SD (2003) Oral steroid treatment of sudden senosrineural hearing loss: a ten year retrospective analysis. Otol Neurotol 24:728-733
  13. Cinamon U, Bendet E, Kronenberg J (2001) Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 258:477-480
  14. Conlon BJ, Smith DW (2000) Topical aminoglycoside ototoxicity: attempting to protect the cochlea. Acta Otolaryngol 120:596-599
  15. Conlon BJ, Aran JM, Erre JP, Smith DW (1999) Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant a-lipoic acid. Hear Res 128:40-44
  16. Corvera J, Corvera G (1989) Long-term effect of acetazolamide and chlortalidone on the hearing loss of Meniere's disease Am J Otol 10:142-145
  17. Daniels, RL, Shelton C, Harnsberger HR (1998) Ultra high resolution nonenhanced fast spin echo magnetic resonance imaging: cost-effective screening for acoustic neuroma in patients with sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 119:364-369. Außerdem Comment in Otolaryngol Head Neck Surg (1998) 121:846
  18. Dauman R, Poisot D, Cros AM, Zennaro O, Bertrand B, Duclos JY, Esteben D, Milacic M, Boudey C, Bebear JP (1993) Surdites brusques: etude comparative randomisee de deux modes d'administration de l'oxygenotherapie hyperbare associee au Naftidrofuryl. Rev Laryngol Otol Rhinol (Bord) 114:53-58
  19. Desloovere C, Knecht R (1995) Infusionstherapie bei Horsturz. Reduktion des Juck-reizrisikos nach Hydroxyethylstärke (HES) unter Erhalt des Therapieerfolges - eine prospektive randomisierte Studie. Laryngorhinootologie 74:468-472
  20. Desloovere C, Meyer-Breiting E, von Ilberg C (1988) Randomisierte Doppelblind-studie zur Hörsturztherapie: erste Ergebnisse. HNO 36:417-422
  21. Desloovere C, Lörz M, Klima A (1989) Sudden sensorineural hearing loss. Influence of hemodynamical and hemorheological factors on spontaneous recovery and therapy results. Acta Oto-Rhino-Laryngologica Belgica 43:31-37
  22. Dowie J (2000) Role of decision analysis in evaluation of guide lines. Referat, Symposium "Clinical Guidelines and Medical Decision Making" of ESMDM, AWMF and AIME during MIE 2000, Hannover, 31.08.2000
  23. Edamatsu H, Hasegawa M, Oku T, Nigauri T, Kurita N, Watanabe I (1985) Treatment of sudden deafness: carbon dioxide and oxygen inhalation and steroids. Clin Otolaryngol 10:69-72
  24. Encke A, Reinauer H, Lorenz W (2001) Weiterentwicklung der Qualität der Gesundheitsversorgung unter Nutzung der evidenzbasierten Medizin und Pflege (Leitlinien). Stellungnahme der AWMF zu Fragen des Runden Tisches, AWMF-Publikation im Internet, 27.08.2001
  25. Fattori B, Berrettini S, Casani A, Nacci A, De Vito A, De Iaco G (2001) Sudden hypoacusis treated with hyperbaric oxygen therapy: a controlled study. Ear Nose Throat J 80:655-660
  26. Fetterman BL, Saunders JE, Luxford WM (1996) Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 17:529-536
  27. Flunkert C, Schwab B, Heermann R, Lenarz Th (2001) Hyperbare Sauerstofftherapie als Primärtherapie akuter Innenohrschädigungen - Abschlussergebnisse einer prospektiven randomisierten Studie. Mitteilungen der Norddtsch Gesellsch f. Otorhinolaryngologie und zervikofaziale Chirurgie:28-31
  28. Friedrich G, Ott E (1991) Prospektiv randomisierte Studie zum Wirkungsvergleich zwischen 10% HES 200/0.5 und 6% HES 200/0.5 bei Hörsturzpatienten. Laryngo-rhinootologie 70:670-674
  29. Goto F, Fujita T, Kitani Y, Kanno M, Kamei T, Ishii H (1979) Hyperbaric oxygen and stellate ganglion blocks for idiopathic sudden hearing loss. Acta Otolaryngol 88:335-342
  30. Gröschenig E, Albegger K, Dieterich, HJ, Franke RP, Gerlach E, Jurecka W, Kiesewetter H, Koch G, Ladurner G, Pölz W, Schimetta W, Schneeberger R, Volgger R, Wilhelm HJ, Zelger J (1998) Hydroxyethylstarch-related pruritus: a prospective multicentre investigation of 544 patients. Perfusion 11:62-69
  31. Guseinov NM, Konstantinova NP, Lukich VL, Mel'nikova LN, Vernekin EB (1989) Our experience in the hyperbaric oxygenation treatment of patients with acute senso-rineural hearing disorder of vascular etiology. [Article in Russian] Vestn Otorino-laringol Jul-Aug (4):76-79
  32. Gutmann R, Mees K (1995) Piracetam-Infusionen bei akutem Tinnitus und Hörsturz. Fortschr Med 113:288-290
  33. Hoffmann F, Beck C, Schutz A, Offermann P (1994) Ginkgoextrakt EGb 761 (Tebonin)/HAES versus Naftidrofuryl (Dusodril)/HAES. Eine randomisierte Studie zur Horsturztherapie. Laryngorhinootologie 73:149-152
  34. Huang TS, Chan ST, Ho TL, Su JL, Lee FP (1988) Hypaque and steroids in the treatment of sudden sensorineural hearing loss. Clin Otolaryngol. 1989 Feb; 14(1): 45-51
  35. Hultcrantz E, Stenquist M, Lyttkens L (1994) Sudden deafness: a retrospective evaluation of dextran therapy. ORL J Otorhinolaryngol Relat Spec 56:137-142
  36. Inci E, Erisir F, Ada M, Ozturk O, Guclu E, Oktem F, Toprak M (2002) Hyperbaric oxygen treatment in sudden hearing loss after unsuccessful medical treatment. [Article in Turkish] Kulak Burun Bogaz Ihtis Derg 9:337-341
  37. Jean RC, Aimard A, Amoros JF, Ohresser P (1984) Fiabilite de l'oxygenotherapie hyperbare dans le traitement des surdites brusques. Méd Aéron Spat Méd Subaq Hyperb 3:31-37
  38. Jenicek M (1999) Clinical Case Reporting in Evidence-based Medicine, S. 1-154, Butterworth-Heinemann, Oxford
  39. Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D (2003) Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol 24:572-575
  40. Kallinen J, Laurikainen E, Laippala P, Grenman R (1997) Sudden deafness: a comparison of anticoagulant therapy and carbogen inhalation therapy. Ann Otol Rhinol Laryngol 106:22-26
  41. Kanzaki J, Taiji H, Ogawa K (1988) Evaluation of hearing recovery and efficacy of steroid treatment in sudden deafness. Acta Otolaryngol Suppl 456:31-36
  42. Kanzaki J, Inoue Y, Ogawa K, Fukuda S, Fukushima K, Gyo K, Yanagihara N, Hoshino T, Ishitoya J, Toriyama M, Kitamura K, Murai K, Nakashima T, Niwa H, Nomura Y, Kobayashi H, Oda M, Okamoto M, Shitara T, Sakagami M, Tono T, Usami S (2003) Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 30:123-127
  43. Kaiser H, Kley HK (1997) Cortisontherapie. Corticoide in Klinik und Praxis. 10. Aufl., Thieme, Stuttgart
  44. Kau RJ, Sendtner-Gress K, Ganzer U, Arnold W (1997) Effectiveness of hyperbaric oxygen therapy in patients with acute and chronic cochlear disorders. ORL J Otorhino-laryngol Relat Spec 59:79-83
  45. Kestler M, Strutz J, Heiden C (2001) Hyperbare Oxygenation in der Frühbehandlung des Hörsturzes. HNO 49:719-723
  46. Klemm E, Schaarschmidt W (1989) Epidemiologische Erhebungen zu Hörsturz, Vestibularisstörungen und Morbus Meniere. HNO-Prax 14:295-299
  47. Klemm E (1991) Therapiebeginn und Therapieart des Hörsturzes: Eine Betrachtung zugleich aus medico-legaler Sicht. Laryngo-Rhino-Otol 70:359-361
  48. Kronenberg J, Almagor M, Bendet E, Kushnir D (1992) Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study. Laryngoscope 102:65-68
  49. Kubo T, Matsunaga T, Asai H, Kawamoto K, Kusakari J, Nomura Y, Oda M, Yanagita N, Niwa H, Uemura T, et al. (1988) Efficacy of defibrinogenation and steroid therapies on sudden deafness. Arch Otolaryngol Head Neck Surg 114:649-652
  50. Lamm K (2004) Hyperbaric oxygen therapy for the treatment of acute cochlear disorders and tinnitus. Editorial ORL J Otorhinolaryngol Relat Spec 66: in press (im Februar).
  51. Lamm K, Arnold W (1999) How useful is corticosteroid treatment in cochlear disorders? Otorhinolaryngol Nova 9:203-216
  52. Lamm K, Arnold W (2000) The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO2 and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res 141:199-219
  53. Lamm K, Lamm H, Arnold W (1998) Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise induced hearing loss and tinnitus. A literature survey. In: Yanagita N, Nakashima T (eds): Hyperbaric Oxygen Therapy in Otorhinolaryngology. Adv Otorhinolaryngol 54:86-99
  54. Laskawi R, Schrader B, Schröder M, Poser R, von der Brelie R (1987) Zur Therapie des Hörsturzes - Naftidrofuryl (Dusodril) und Pentoxifyllin (Trental) im Vergleich. Laryngol Rhinol Otol 66:242-245
  55. Lenarz T (1989) Hörsturztherapie mit dem Calciumantagonisten Nimodipin. Ergebnisse einer vergleichenden Studie. Laryngorhinootologie 68:634-637
  56. Leunig A, Szeimies RM, Wilmes E, Gutmann R, Stolz W, Feyh J (1995) Klinische und elektronenmikroskopische Untersuchung zur Hörsturztherapie mit der Kombina-tion 10% HES 200/0.5 und Pentoxifyllin. Laryngorhinootologie 74:135-140
  57. Linßen O, Schultz-Coulon H-J (1997) Prognostische Kriterien beim Hörsturz. HNO 45:22-29
  58. Liu JM, Ma L, He WP (2002) Therapeutic effect of puerarin therapy on sudden deafness. [Article in Chinese] Di Yi Jun Yi Da Xue Xue Bao 22:1044-1045
  59. Lorenz W (1999) Bekanntmachungen und Informationen. Deutsche Gesellschaft für Chirurgie - Mitteilungen 4/99:288-290
  60. Mann W, Beck C, Beck C (1986) Calcium antagonists in the treatment of sudden deafness. Arch Otorhinolaryngol 243:170-173
  61. Mattox DE, Simmons FB (1977) Natural history of sudden sensorineural hearing loss. Ann Otol 86:463-480
  62. Michel O (1998) Morbus Menière und verwandte Gleichgewichtsstörungen. Thieme, Stuttgart
  63. Michel O, Matthias R (1991) Plazebokontrollierte Doppelblindstudie zur Hörsturzbehandlung mit einem stabilen Prostacyclinanalog. Laryngorhinootologie 70:255-259
  64. Michel O, Jahns T, Joost-Enneking M, Neugebauer P, Streppel M, Stennert E (2000) Das antiphlogistisch-rheologische Infusionsschema nach Stennert in der Behandlung von cochleovestibulären Störungen. HNO 48:165-169
  65. Michels E, Matzker J (1988) Der Hörsturz und seine Therapie. Klinische Studie an 548 Fällen.Laryngol Rhinol Otol 67:171-176
  66. Minoda R, Masuyama K, Habu K, Yumoto E (2000) Initial steroid hormone dose in the treatment of idiopathic sudden deafness. Am J Otol 21:819-825
  67. Moskowitz D, Lee KJ, Smith HW (1984) Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 94:664-666
  68. Mosnier I, Bouccara D, Atassi-Dumont M, Sterkers O (1998) Traitements des surdites brusques: etude retrospective de 144 cas. Rev Laryngol Otol Rhinol (Bord) 119:119-128
  69. Murakawa T, Kosaka M, Mori Y, Fukazawa M, Misaki K (2000) Treatment of 522 patients with sudden deafness performed oxygenation at high pressure. [Article in Japanese] Nippon Jibiinkoka Gakkai Kaiho 103:506-515
  70. Murphy M, Carmichael AJ, Lawler PG, White M, Cox NH (2001) The incidence of hydroxyethyl starch-associated pruritus. Brit J Dermatol 144:973-976
  71. Nakashima T, Kuno K, Yanagita N (1989) Evaluation of prostaglandin E1 therapy for sudden deafness. Laryngoscope 99:542-546
  72. Nakashima T, Fukuta S, Yanagita N (1998) Hyperbaric oxygen therapy for sudden deafness. In: Yanagita N, Nakashima T (eds): Hyperbaric Oxygen Therapy in Otorhinolaryngology. Adv Otorhinolaryngol 54:100-109.
  73. Nakashima T, Itoh A, Misawa H, Ohno Y (2000) Clinicoepidemiologic features of sudden deafness diagnosed and treated at university hospitals in Japan. Otolaryngol Head Neck Surg 123:593-597
  74. Ogawa K, Takei S, Inoue Y, Kanzaki J (2002) Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study. Otol Neurotol 23:665-668
  75. Ohresser P, Jean C, Alessandrini G, Sainty JM (1980) Le traitement par oxygénothérapie hyperbare des surdités brusques: étude à propos de 160 surdités. Méd Aéron Spat Méd Subaq Hyperb 19:58-60
  76. Pilgramm M, Vestner HJ, Schumann K (1986) Niedermolekulare Hydroxyethylstärke oder niedermolekulares Dextran bei akuten Innenohrerkrankungen ? Eine randomisierte Vergleichsstudie. Laryngol Rhinol Otol 65:377-380
  77. Pilgramm M (1991) Zur hämodilutorischen Therapie akuter Innenohrschäden. Acta Med Austriaca 18 Suppl 1:60-62
  78. Poser R, Hirche H (1992) Randomisierte Doppelblindstudie zur Horsturztherapie. Niedermolekulares Dextran + Naftidrofuryl vs. niedermolekulares Dextran + Plazebo. HNO 40:396-389.
  79. Probst R, Tschopp K, Ludin E, Kellerhals B, Podvinec M, Pfaltz CR (1992) A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol 112:435-443
  80. Racic G, Maslovara S, Roje Z, Dogas Z, Tafra R (2004) Hyperbaric oxygen in the treatment of sudden hearing loss. ORL J Otorhinolaryngol Relat Spec 66: in press (im Februar).
  81. Reisser CH, Weidauer H (2001) Ginkgo biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study. Acta Otolaryngol 121:579-584
  82. Rybak LP, Husain K, Whithworth C, Somani SM (1999) Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system. Toxicol Sci 47:195-202
  83. Saeki N, Kitahara M (1994) Assessment of Prognosis in Sudden Deafness. Acta Otolaryngol (Stockh) Suppl 510:56-61
  84. Samim E, Kilic R, Ozdek A, Gocmen H, Eryilmaz A, Unlu I (2003) Combined treatment of sudden sensorineural hearing loss with steroid, dextran and piracetam: experience with 68 cases. Eur Arch Otorhinolaryngol Published online: Aug 22, 2003
  85. Schoenbaum SC (2001) In: Gross PA, Greenfield S, Cretin S, Ferguson J, Grimshaw J, Grol R et al. Optimal methods for guideline implementation. Conclusions from Leeds Castle Meeting. Med Care 39: Suppl 2
  86. Shiraishi T, Kubo T, Matsunaga T (1991) Chronological study of recovery of sudden deafness treated with defibrinogenation and steroid therapies. Acta Otolaryngol 111: 867-871
  87. Shiraishi T, Kubo T, Okumura S, Naramura H, Nishimura M, Okusa M, Matsunaga T (1993) Hearing recovery in sudden deafness patients using a modified defibrinogena-tion therapy. Acta Otolaryngol Suppl 501:46-50
  88. Shiraishi T, Satou Y, Makashima K (1998) Hyperbaric Oxygenation therapy in idiopathic sudden sensory neural hearing loss. [Article in Japanese] Nippon Jibiinkoka Gakkai Kaiho 101: 1380-1384
  89. Staindl O, Hibler N, Grandy Th (1979) Der Hörsturz. Wiener Med Wschr 29:648-652
  90. Stokroos RJ, Albers FW, Tenvergert EM (1998) Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial. Acta Otolaryngol 118:488-495
  91. Strutz J (2000) Stellenwert des Stennertschemas in der Hörsturztherapie. HNO 48: 165-169
  92. Suckfüll M (1999) Clinical Utility of LDL-apheresis in the Treatment of Sudden Hearing Loss: a Prospective Randomized Study. Acta Otolaryngol 119:763-766
  93. Suckfüll M; Hearing Loss Study Group (2002) Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 360:1811-1817. Erratum in: Lancet 361:1916
  94. Sun AH, Wang ZM, Xiao SZ, Li ZJ, Ding JC, Li JY, Kong LS (1992) Idiopathic sudden hearing loss and disturbance of iron metabolism. A clinical survey of 426 cases. ORL J Otorhinolaryngol Relat Spec 54:66-70
  95. Suzuki H, Furukawa M, Kumagai M, Takahashi E, Matsuura K, Katori Y, Shimomura A, Kobayashi T (2003) Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Otolaryngol 123:46-50
  96. Topuz E, Yigit O, Cinar U, Seven H (2003) Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol Published online: 29 October 2003
  97. Tucci DL, Farmer JC Jr, Kitch RD, Witsell DL (2002) Treatment of sudden sensori-neural hearing loss with systemic steroids and valacyclovir. Otol Neurotol 23: 301-308
  98. Uri N, Doweck I, Cohen-Kerem R, Greenberg E (2003) Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 128:544-549
  99. Veldman JE, Hanada T, Meeuwsen F (1993) Diagnostic and therapeutic dilemmas in rapidly progessive sensorineural hearing loss. Acta Otolaryngol (Stockh) 113:303-306
  100. Vollrath M, Marangos N, Hesse G (1990) Die Dehydratationstherapie des Tieftonhörverlustes. Eine Alternative zur rheologischen Therapie? HNO 38:154-157
  101. Weinaug P (1984) Die Spontanremission beim Hörsturz. HNO 32:346-351
  102. Wilhelm HJ (1987) Der Hörsturz - ein Beitrag zur Problematik der Diagnose und Therapie. In: Ganz H, Schätzle W (Hrsg.) HNO Praxis Heute 7:15-30
  103. Wilhelm HJ, Schätzle W, Breyer D (1980) Früh-und Spätergebnisse sowie Rezidiv-quote behandelter Hörstürze. Extracta Otorhinolaryngologica 2:341-353
  104. Wilhelm HJ, Lotte W, Luckhaupt H, Imhäuser S, Morgenstern C, Hörmann K, Elies S (1992) Behandlung des idiopathischen Hörsturzes. Naftidrofuryl in Kombination mit Hämodilution. Münch Med Wschr 134:620-624
  1. a. Wilhelm T, Agababov V, Lenarz T (2001) Rheologische Infusionstherapie, Neurotransmitterapplikation und Lidocain-Injektion bei Tinnitus - ein therapeutisches Stufenkonzept. HNO (2001) 49: 93-101
  2. Wilson WR, Byl FM, Laind N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 106:772-776
  3. Yanagita N, Nakashima, T, Ohno Y, Kanzaki J, Shitara T (1994) Estimated Annual Number of Patients Treated for Sensorineural Hearing Loss in Japan. Acta Otolaryngol (Stockh) Suppl 514:9-13
  4. Zadeh MH, Storper IS, Spitzer JB (2003) Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg 128:92-98
  5. Zastrow G, Arndt HJ (1987) Klinik und Therapie des Hörsturzes. Nach dem Patientengut der Hals-, Nasen-, Ohrenklinik der Stadtischen Kliniken Wiesbaden aus den Jahren 1974 bis 1982. Laryngol Rhinol Otol 66:237-241
  6. Zennaro O, Dauman R, Poisot A, Esteben D, Duclose JY, Bertrand B, Cros AM, Milacic M, Bebear JP (1993) Interet de l'association hemodilution normovolemique-oxygenotherapie hyperbare dans le traitement des surdites brusques a partir d'une etude retrospective. Ann Otolaryngol Chir Cervicofac 110:162-169
  7. Zenner HP, Zimmermann U (2002) Pathophysiologie der chronischen Innenohrschwerhörigkeit. In: HNO Praxis heute, Bd. 21, Hrsg. Biesinger, E, Iro, H, S. 1-26, Springer, Berlin-Heidelberg-New York


Anhänge:


Verfahren zur Konsensbildung

Erstellungsdatum:

Erste S1-Leitlinie: 03. August 1996

Letzte Überarbeitung:

Januar 2004

Überprüfung geplant:

2006
Zurück zur AWMF-Leitseite


Stand der letzten Aktualisierung: Januar 2004
Copyright ©: Dt. Ges. f. HNO-Heilkunde, Kopf- und Hals-Chirurgie
Autorisiert für elektronische Publikation: AWMF online
HTML-Code optimiert: 10.05.2007; 10:29:42